StockData
Clarivate PLC logo

Clarivate PLC (CLVT) stock

CLVTNYSEServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 7/3075% below fair value
$2.19−0.10 (-4.37%)

Close on Nov 17, 2026Market cap $1.40BP/E –Yield –

Earnings

Clarivate's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 23, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q3 FY2026
$567.90M
-8.9% on a year earlier
Adjusted diluted EPS, Q3 FY2026
$0.21
$0.18 a year earlier
Latest guidance
Raised
Nov 3, 2026 · 19 items

Quarterly results

Revenue and earnings per share from each of Clarivate's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 23, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 3, 2026before the open$567.90M-8.9%-$0.13$0.21Release
Q2 FY2026ended Jun 30, 2026Jul 29, 2026before the open$587.30M-5.5%-$0.42$0.19Release
Q1 FY2026ended Mar 31, 2026Apr 29, 2026before the open$585.50M-1.4%-$0.06$0.18Release
Q4 FY2025ended Dec 31, 2025Feb 24, 2026before the open$617.00M-6.9%$0.00$0.20Release
Q3 FY2025ended Sep 30, 2025Oct 29, 2025before the open$623.10M+0.1%-$0.04$0.18Release
Q2 FY2025ended Jun 30, 2025Jul 30, 2025before the open$621.40M-4.4%-$0.11$0.18Release
Q1 FY2025ended Mar 31, 2025Apr 29, 2025before the open$593.70M-4.4%-$0.15$0.14Release
Q4 FY2024ended Dec 31, 2024Feb 19, 2025before the open$663.00M-3.0%-$0.27$0.21Release
Q3 FY2024ended Sep 30, 2024Nov 6, 2024before the open$622.20M-3.9%-$0.09$0.19Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open$650.30M-2.8%-$0.46$0.20Release
Q1 FY2024ended Mar 31, 2024May 8, 2024before the open$621.20M-1.3%-$0.14$0.14Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Clarivate's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
RevenuesGAAPQ4 FY2026$490.00M – $510.00M–NewNov 3, 2026
Adjusted EBITDAnon-GAAPQ4 FY2026$215.00M – $235.00M–NewNov 3, 2026
Adjusted Diluted EPSnon-GAAPQ4 FY2026$0.14 – $0.18–NewNov 3, 2026
Free Cash Flownon-GAAPQ4 FY2026$85.00M – $105.00M–NewNov 3, 2026
ACV Organic Growthnon-GAAPQ4 FY2026+1.75% – +2.25%–NewNov 3, 2026
Adjusted EBITDA Marginnon-GAAPQ4 FY202644% – 46%–NewNov 3, 2026
Recurring Organic Revenue Growthnon-GAAPQ4 FY2026+2% – +2.5%–RaisedNov 3, 2026
Recurring Organic Revenue GrowthFY2026+0.75% – +2.25%–NewFeb 24, 2026
RevenuesGAAPFY2026$1.97B – $1.99B–NewNov 3, 2026
RevenuesGAAPFY2026$1.94B – $2.04B–NewJul 29, 2026
RevenuesFY2026$2.30B – $2.42B$2.30B – $2.42BReaffirmedApr 29, 2026
Revenues, Including Discontinued Operationsnon-GAAPFY2026$2.30B – $2.42B–NewJul 29, 2026
Adjusted EBITDAnon-GAAPFY2026$865.00M – $885.00M–NewNov 3, 2026
Adjusted EBITDAnon-GAAPFY2026$980.00M – $1.04M$980.00M – $1.04BLoweredJul 29, 2026
Net income (loss) per shareGAAPFY2026-$0.65 – -$0.62–NewNov 3, 2026
Net income (loss) per shareGAAPFY2026-$0.64 – -$0.54-$0.29 – -$0.19LoweredJul 29, 2026
Adjusted Diluted EPSnon-GAAPFY2026$0.73 – $0.77–NewNov 3, 2026
Adjusted Diluted EPSnon-GAAPFY2026$0.70 – $0.80$0.70 – $0.80ReaffirmedJul 29, 2026
Free Cash Flownon-GAAPFY2026$320.00M – $340.00M–NewNov 3, 2026
Free Cash Flownon-GAAPFY2026$365.00M – $435.00M$365.00M – $435.00MReaffirmedJul 29, 2026
Capital expendituresGAAPFY2026$230.00M–NewNov 3, 2026
Capital expendituresGAAPFY2026-$245.00M-$250.00MRaisedJul 29, 2026
ACV Organic Growthnon-GAAPFY2026+1.75% – +2.25%–NewNov 3, 2026
ACV Organic Growthnon-GAAPFY2026+2% – +3%–NewJul 29, 2026
Adjusted EBITDA Marginnon-GAAPFY202643% – 45%–NewNov 3, 2026
Adjusted EBITDA Marginnon-GAAPFY202642% – 43.5%42% – 43.5%ReaffirmedJul 29, 2026
Net cash provided by operating activitiesGAAPFY2026$550.00M – $570.00M–RaisedNov 3, 2026
Net cash provided by operating activitiesGAAPFY2026$610.00M – $680.00M$615.00M – $685.00MRaisedJul 29, 2026
Net income (loss)GAAPFY2026-$154.00M – -$144.00M–NewNov 3, 2026
Net income (loss)GAAPFY2026-$418.00M – -$353.00M-$189.00M – -$124.00MLoweredJul 29, 2026
Net income (loss) marginGAAPFY2026-7.8% – -7.3%–NewNov 3, 2026
Net income (loss) marginGAAPFY2026-8.2% – -5.1%–NewFeb 24, 2026
Organic ACVFY2026+2% – +3%+2% – +3%ReaffirmedApr 29, 2026
Recurring Organic Revenue Growthnon-GAAPFY2026+1% – +1.5%–LoweredNov 3, 2026
Recurring Organic Revenue Growthnon-GAAPFY2026+0.75% – +2.25%–LoweredJul 29, 2026
Recurring Organic Revenue GrowthFY2026+0.75% – +2.25%–LoweredApr 29, 2026

Guidance history

Every forecast Clarivate put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 3, 2026Capital expendituresFY2026$230.00MNew
Nov 3, 2026Adjusted EBITDAQ4 FY2026$215.00M – $235.00MNew
Nov 3, 2026Adjusted EBITDAFY2026$865.00M – $885.00MNew
Nov 3, 2026Adjusted Diluted EPSQ4 FY2026$0.14 – $0.18New
Nov 3, 2026Adjusted Diluted EPSFY2026$0.73 – $0.77New
Nov 3, 2026Net income (loss) per shareFY2026-$0.65 – -$0.62New
Nov 3, 2026Free Cash FlowQ4 FY2026$85.00M – $105.00MNew
Nov 3, 2026Free Cash FlowFY2026$320.00M – $340.00MNew
Nov 3, 2026Adjusted EBITDA MarginQ4 FY202644% – 46%New
Nov 3, 2026ACV Organic GrowthQ4 FY2026+1.75% – +2.25%New
Nov 3, 2026Recurring Organic Revenue GrowthQ4 FY2026+2% – +2.5%Raised
Nov 3, 2026Net income (loss) marginFY2026-7.8% – -7.3%New
Nov 3, 2026Adjusted EBITDA MarginFY202643% – 45%New
Nov 3, 2026ACV Organic GrowthFY2026+1.75% – +2.25%New
Nov 3, 2026Recurring Organic Revenue GrowthFY2026+1% – +1.5%Lowered
Nov 3, 2026Net income (loss)FY2026-$154.00M – -$144.00MNew
Nov 3, 2026Net cash provided by operating activitiesFY2026$550.00M – $570.00MRaised
Nov 3, 2026RevenuesFY2026$1.97B – $1.99BNew
Nov 3, 2026RevenuesQ4 FY2026$490.00M – $510.00MNew
Jul 29, 2026Capital expendituresFY2026-$245.00MRaised

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Clarivate filed with the SEC as exhibits to Form 8-K or 6-K

  1. News
  2. News
  3. News
  4. Results
  5. Results
  6. News
  7. News
  8. News
  9. News
  10. Update
  11. Results
  12. Results
  13. Update
  14. Update
  15. Update

See a number that looks wrong?